| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UKNOWN |
| UNII: | 4971UQC7F3 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Complement C5 inhibitor | ClinicalTrials Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Antiphospholipid Syndrome | 2 | D016736 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3990025 |
| FDA SRS | 4971UQC7F3 |
CONTENTS